Company Filing History:
1 out of 1,743 
1 out of 26 
1 out of 229 
Years Active: 2018
Title: Julie Gertner-Dardenne: Innovator in Therapeutic Antagonists
Introduction
Julie Gertner-Dardenne is a prominent inventor based in Valbonne-Sophia Antipolis, France. She has made significant contributions to the field of therapy through her innovative research and development. Her work focuses on the interaction between BTLA and HVEM, which has implications for therapeutic applications.
Latest Patents
Julie holds a patent titled "Antagonist of the BTLA/HVEM interaction for use in therapy." This invention relates to an antagonist that increases the proliferation of Vγ9Vδ2 T cells, showcasing her commitment to advancing therapeutic options.
Career Highlights
Throughout her career, Julie has worked with esteemed organizations such as the Institut National de la Santé et de la Recherche Médicale and the Institut Jean Paoli & Irene Calmettes. Her experience in these institutions has allowed her to contribute to groundbreaking research in the medical field.
Collaborations
Julie has collaborated with notable colleagues, including Daniel Olive and Christine Pasero. These partnerships have further enriched her research and development efforts.
Conclusion
Julie Gertner-Dardenne is a trailblazer in the field of therapeutic antagonists, with a focus on enhancing T cell proliferation. Her innovative work and collaborations continue to impact the medical research landscape.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.